LivaNova PLC Cost-method Investments, Other than Temporary Impairment
LivaNova PLC (LIVN) reported Cost-method Investments, Other than Temporary Impairment of $8.56 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostmethodInvestmentsOtherThanTemporaryImpairment · last filed 2018-02-28
- LivaNova PLC cost-method investments, other than temporary impairment for the quarter ending 2016-12-31 was -$19.38M.
- LivaNova PLC cost-method investments, other than temporary impairment for the quarter ending 2016-09-30 was $19.38M.
- LivaNova PLC cost-method investments, other than temporary impairment for the quarter ending 2015-10-18 was $0.00.
- LivaNova PLC cost-method investments, other than temporary impairment for fiscal 2017 was $8.56M.
- LivaNova PLC cost-method investments, other than temporary impairment for fiscal 2016 was $0.00.
- LivaNova PLC cost-method investments, other than temporary impairment for fiscal 2015 was $0.00.
- LivaNova PLC cost-method investments, other than temporary impairment for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
| Period end | Cost-method Investments, Other than Temporary Impairment 3 month | Cost-method Investments, Other than Temporary Impairment 6 month | Cost-method Investments, Other than Temporary Impairment 8 month | Cost-method Investments, Other than Temporary Impairment 8 month as first filed | Cost-method Investments, Other than Temporary Impairment 9 month | Cost-method Investments, Other than Temporary Impairment 12 month | Cost-method Investments, Other than Temporary Impairment 20 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $8.56M 10-K · filed 2018-02-28 | ||||||
| 2016-12-31 | -$19.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 10-K · filed 2018-02-28 | ||||
| 2016-09-30 | $19.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $19.38M 10-Q · filed 2016-11-02 | |||||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-05 | ||||||
| 2015-12-31 | $5.06M 10-K · filed 2018-02-28 | $5.13M 10-KT · filed 2016-03-04 | $5.13M 10-K · filed 2018-02-28 | ||||
| 2015-10-18 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $2.06M 10-Q · filed 2016-11-02 | |||||
| 2015-07-24 | $2.06M 10-Q · filed 2016-08-05 | ||||||
| 2015-04-24 | $0.00 10-K · filed 2018-02-28 | ||||||
| 2014-12-26 | $0.00 10-K · filed 2018-02-28 | ||||||
| 2014-04-25 | $0.00 10-K · filed 2017-03-01 | ||||||
| 2013-04-26 | $4.06M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |